SDBP Online Educational Package: Management of Complex ADHD - Society for Developmental and Behavioral Pediatrics

SDBP is offering this online focused package on the Management of Complex Attention-Deficit /Hyperactivity Disorder (ADHD). Aimed at improving the care of ADHD and coexisting conditions, this package includes a curated toolkit of resources to help support your clinical practice.

Core audiences include:

general pediatricians
practicing developmental-behavioral pediatricians
physicians in training
advanced practice nursing professionals
clinical/pediatric psychologists
child/adolescent psychiatrists

The track provides guidance on incorporating the SDBP Complex ADHD Clinical Practice Guideline (CPG) into current practice, advancing participants’ knowledge of:

- Psychosocial treatments for ADHD across different developmental stages,
  from early childhood through Adolescence.
- Medication treatment of adolescent patients, focusing on prevention of
  stimulant misuse and diversion.
- Resources and quality improvement efforts aimed at smooth integration
  of the Complex ADHD CPG into clinical care.
- Collaborative and culturally-sensitive approaches to ADHD care, including
  for patients of color.

With over 10 hours of content, you get access (for one year) to seven recorded sessions that were presented at the Society for Developmental and Behavioral Pediatrics 2020 Virtual Annual Meeting.

COST $150 - one year access

Click here to purchase

Sessions Included:

Managing Complex ADHD in Children of Color (1.5 hours)

Evidence suggests that there are significant racial and ethnic disparities in the diagnosis, treatment and management of ADHD that negatively impact children of color, yet providers are often unaware of these inequities or unprepared to address them. This session first reviews ADHD prevalence and diagnosis/recognition by racial and ethnic group. In addition, variations in behavioral, educational, and mental health outcomes for children of color with Complex ADHD are described. Finally, differences in ADHD management by racial/ethnic group are presented and barriers to care are highlighted, with recommendations made and tools provided to enable culturally respectful care for children of color.

Authors

Adiaha Spinks-Franklin, MD,MPH, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX; Tanya Froehlich, MD, MS, Cincinnati Children’s Hospital, Cincinnati , OH; Irene Loe, MD, Lucile Salter Packard Children’s Hospital/Stanford University, Palo Alto, CA; Purnima Valdez, MD, Duke University School of Medicine, Durham, NC; Jeff Yang, MD, LA Children’s Hospital, Los Angeles, CA; Yi Hui Liu, MD, University of California San Diego, San Diego, CA; Jennifer Walton, MD, MPH, Nationwide Children’s Hospital, Columbus, OH; Tahira Adelekan, MD, Dayton Children’s Hospital, Dayton, OH; Shruti Mittal, MD, Atrium Health, Concord, NC; July Jean-Cuevas, MD, Children’s Mercy Kansas City, Kansas City, MO; Lorena Ferreira-Corzo, MD, Rush Pediatrics, Chicago, IL; Silvia Pereiras-Smith, MD, MUSC, Charleston, SC; Hanien Edrees, MD, Cincinnati Children’s Hospital, Cincinnati , OH; Lee Pachter, DO, Christian Care, Philadelphia , PA; Jessica Smith, LMSW, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX; Kelly Kamimura-Nishimura, MD,MS, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

SDBP Complex ADHD Guidelines: Making Guidelines Meaningful to the Child, Family, School Team, and Inter-Professional Colleagues (2 hours)

This interactive workshop will teach participants how to develop a comprehensive treatment plan for the child or adolescent who presents with Complex ADHD. The workshop identifies observable behaviors which present in the child with Complex ADHD. Participants will learn about how these observable behaviors help identify underlying impairments or challenges, and how they reveal targets for intervention. At the conclusion of this workshop, Developmental-Behavioral Pediatric practitioners will be positioned to provide the psychoeducation needed for successful treatment, collaborate with the child and family, and coordinate care with professional and non-professional adults located in schools, clinics, and other settings.

Authors

Behavioral Parent Training for Complex Presentations: Fundamentals, Adaptations, and Strategies for Expanding Access (2 hours)

The SDBP Complex ADHD Guidelines and AAP ADHD Guidelines both emphasize the importance of behavioral supports, yet access remains limited for many children. Behavioral parent training (BPT) is an efficacious and cost-effective intervention modality readily adapted for developmental-behavioral clinic settings. This workshop will provide a primer on BPT, adaptations to address comorbid conditions (autism, anxiety), and extensions of BPT models to increase access (group, telehealth, self-guided, etc.). Presenters will embed issues related to diversity, access, and supporting family engagement throughout the workshop, closing with discussion regarding how attendees can improve access to evidence-based behavioral strategies in their work settings.

Authors

Implementing the Complex ADHD Guideline: Shared Decision Making and Toolkit Resources (1.5 hours)

This session will address several themes related to implementation of the Complex ADHD Guidelines through the lens of shared decision making (SDM). The session will highlight the value of SDM as a family- and patient-centered strategy for approaching treatment planning around complex ADHD. This session will also review evidence-based screening tools and treatment recommendation resources for supporting three specific populations - preschoolers with ADHD, children with coexisting ADHD and anxiety, and adolescents and transitional age youth with ADHD.

Authors

Authors: Emily Haranin, PhD, University of Southern California Keck School of Medicine, Los Angeles, CA; Tanya Froehlich, MD, MS, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH; Yi Hui Liu, MD, MPH, FAAP, University of California San Diego School of Medicine, San Diego, CA; Melissa R. Dvorsky, PhD, University of California San Francisco, San Francisco, CA; Lisa Campbell, MD, Children's Mercy Hospital, Kansas City, MO

ADHD SIG Clinical Innovation Spotlight: Managing and Preventing Medication Misuse and Diversion in Adolescents and Young Adults with ADHD (1.5 hours)

The new SDBP Clinical Practice Guideline (CPG) for Complex ADHD emphasizes treatment across the lifespan. A very serious problem among adolescents and young adults with ADHD is misuse and diversion of psychostimulant medications. As part of the CPG Track, we welcome Brooke Molina of the University of Pittsburgh to discuss this important topic. Dr. Molina is among our field's top leaders in psychosocial interventions for ADHD, having served as an investigator and consultant on the influential Multimodal Treatment of ADHD Study and receiving funding for 25 years for her clinical research on co-occurring substance use and ADHD in adolescents.

Authors

Create Your Own Quality Improvement Project to Earn Maintenance of Certification Part 4 Credit Using the Complex ADHD Guidelines (2 hours)

Earn American Board of Pediatrics (ABP) Maintenance of Certification (MOC) Part 4 credit with QI projects you are already doing in your own practice! Workshop participants will (1) learn how to find existing MOC part 4 activities, (2) become familiar with ABP standards for QI projects that are eligible for MOC part 4 credit, and (3) learn how to use standard QI tools and methods to develop their own MOC 4-eligible projects, using the SDBP Complex ADHD guidelines as an example. Participants should be familiar with the Complex ADHD guideline prior to participating in the workshop.

Authors

Complex ADHD Research Platform – Presentation of 5 abstracts (1.5 hours)

Medication Treatment of Attention-Deficit/Hyperactivity Disorder in Children with Autism Spectrum Disorder: DNPNet Data

To investigate the practice patterns of developmental behavioral pediatricians (DBPs) in the treatment of children with autism spectrum disorder (ASD) and coexisting attention/deficit hyperactivity disorder (ADHD).

Authors

Methylphenidate More Effective Than Guanfacine in Preschoolers with ADHD: A DBPNet Study

To determine the effectiveness of methylphenidate (MPH) versus guanfacine (GUAN) for initial ADHD medication treatment in preschool aged children, and dosages at which the medication was first effective.

Authors

Authors: Elizabeth Harstad, MD, MPH, Boston Children's Hospital, Boston, MA; Justine Shults, PhD, Children's Hospital of Philadelphia, Philadelphia, PA; William J. Barbaresi, MD, Boston Children's Hospital, Boston, MA; Ami Bax, MD, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Jacyln Cacia, BS, Children's Hospital of Philadelphia, Philadelphia, PA; Alexis Deavenport-Saman, DrPH, MPH, Keck School of Medicine, University of Southern California, Children’s Hospital Los Angeles, Los Angeles, CA; Sandra Friedman, MD, MPH, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, CO; Angela LaRosa, MD, MSCR, Medical University of South Carolina, Charleston, SC; Irene Loe, MD, Lucile Salter Packard Children’s Hospital/Stanford University, Palo Alto, CA; Shruti Mittal, MD, Atrium Health, Concord, NC; Shelby Tulio, MS, Children's Hospital of Philadelphia, Philadelphia , PA; Douglas Vanderbilt, MD, MS, Keck School of Medicine, University of Southern California, Children’s Hospital Los Angeles, Los Angeles, CA; Nathan Blum, MD, Children's Hospital of Philadelphia, Philadelphia, PA

The Protective Role of Family Resilience for Healthy Weight Behaviors Among Children With ADHD

To investigate the potential protective factor of family resilience for healthy weight behaviors associated with obesity or overweight in children with ADHD.

Authors

Autism Spectrum Disorder and Adverse Events to Selective Serotonin Reuptake Inhibitors in Children and Adolescents

To test the hypothesis that children with autism spectrum disorder have increased adverse events to selective serotonin reuptake inhibitors compared to children without autism spectrum disorder.

Authors

Co-existing conditions Related to Medication Use and Dose to Achieve Effectiveness in Preschoolers with ADHD: A DBPNet Study

Examine coexisting conditions related to medication use and dose to achieve effectiveness in preschoolers with ADHD.

Authors

Authors: Alexis Deavenport-Saman, DrPH, MPH; Douglas L. Vanderbilt, MD, MS, Keck School of Medicine, University of Southern California, Children's Hospital Los Angeles, Los Angeles, CA; Elizabeth Harstad, MD, MPH, Boston Children's Hospital, Boston, MA; Justine Shults, PhD, MS, Children's Hospital of Philadelphia, Philadelphia, PA; William J. Barbaresi, MD, Boston Children's Hospital, Boston, MA; Ami Bax, MD, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Jaclyn Cacia, MS, Children's Hospital of Philadelphia, Philadelphia, PA; Sandra L. Friedman, MD, MPH, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, CO; Angela LaRosa, MD, MSCR, Medical University of South Carolina, Charleston, SC; Irene Loe, MD, Lucile Salter Packard Children’s Hospital/Stanford University, Palo Alto, CA; Shruti Mittal, MD, Atrium Health, Concord, NC, United States; Shelby Tulio, MS; Nathan J. Blum, MD, Children's Hospital of Philadelphia, Philadelphia, PA